What AI says about Biodesix
Biodesix is a leading diagnostic solutions company focused on personalized diagnostics to improve patient care, with a focus on lung disease and early detection. It provides advanced diagnostic tests and custom development services to support biopharma, life sciences, and research institutions in developing diagnostics, tools, and therapeutics (for example Nodify Lung Nodule Risk Assessment and IQLung Cancer Treatment Guidance). The tests have NYS CLEP approval but have not yet been cleared or approved by the FDA.
AI named Biodesix in August 2026.
Questions and answers
Competitors
AI named Biodesix alongside Foundation Medicine, GeneSilico, and Karius.
Sources AI cites
AI cited biodesix.com in these answers, after ascopubs.org.
biodesix.com 13%Other sites 87%